Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-11-07 14:30Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 41.0 yuan, reflecting a 1.91% increase on November 7, 2025, amidst varying capital flows [1][2]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main business revenue of 7.897 billion yuan, a year-on-year increase of 30.1% [3]. - The net profit attributable to shareholders reached 732 million yuan, up 32.36% year-on-year, while the net profit excluding non-recurring items was 679 million yuan, marking a 43.93% increase [3]. - In Q3 2025 alone, the company achieved a main business revenue of 2.601 billion yuan, a 27.71% increase year-on-year, and a net profit of 240 million yuan, up 42.11% year-on-year [3]. Market Position - Steady Medical's total market capitalization stands at 23.876 billion yuan, ranking 4th in the beauty and personal care industry, which has an average market cap of 10.19 billion yuan [3]. - The company has a net asset value of 12.263 billion yuan, leading the industry with a ranking of 1st [3]. - The company's price-to-earnings ratio (P/E) is 24.47, significantly lower than the industry average of 38.65, placing it 2nd in the industry [3]. Capital Flow Analysis - On November 7, 2025, the net inflow of main funds was 2.1403 million yuan, accounting for 0.67% of the total transaction amount, while retail investors experienced a net outflow of 15.5533 million yuan, representing 4.89% of the total [1][2]. - Over the past five days, the stock has seen fluctuations in capital flow, with notable net outflows from retail investors on several days [2]. Analyst Ratings - In the last 90 days, 21 institutions have rated the stock, with 17 buy ratings and 4 hold ratings, indicating a generally positive outlook [4]. - The average target price set by institutions over the past 90 days is 53.83 yuan [4].